Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-08-07

FDA Approved: IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE — Original Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approved Sun Pharmaceutical's original ANDA for ipratropium bromide and albuterol sulfate, a generic inhalation product for treating bronchospasm associ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE (ipratropium bromide and albuterol sulfate)

Snippet

ORIG AP for IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE (IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE)